Rationale: Increased arginase activity contributes to endothelial dysfunction by competition for l-arginine substrate and reciprocal regulation of nitric oxide synthase (NOS). The rapid increase in arginase activity in human aortic endothelial cells exposed to oxidized low-density lipoprotein (OxLDL) is consistent with post-translational modification or subcellular trafficking.
A ccumulating evidence suggests that oxidized low-density lipoprotein (OxLDL) plays an important role in the pathogenesis of atherosclerosis, and this is supported by its abundance in atherosclerotic lesions. 1, 2 A major target for OxLDL-mediated vascular injury in atherogenesis is the aortic intima. 3, 4 Most of these effects occur through OxLDL interaction with its lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). 5 Endothelium plays a major role in the regulation of vascular homeostasis by modulating vasomotor tone and vascular smooth muscle cell growth and migration. Impaired endothelial function is considered to be an early and critical event in atherosclerosis, causing abnormalities in the arterial wall and plaque formation. 6 An emerging paradigm in NO biology is the concept that arginase (Arg) reciprocally regulates NOS activity by competing for l-arginine substrate and effectively inhibiting NO-dependent processes by depleting the substrate pool available for NO biosynthesis. 7 Furthermore, because l-arginine is spatially confined to a minimum of 3 distinct subcellular pools that are regulated by different transporters and enzymes, local concentrations of l-arginine may limit the activity of the different NOS isoforms that are also spatially segregated within the cell. 8 Arg1 and Arg2 are distinct isoforms encoded by different genes. 9, 10 Arg1 has been referred to as the hepatic isoform and catalyzes the final step of the urea cycle although its expression can be induced in a wide variety of cells and tissues by hypoxia and LPS. 11 Arg2 is the principal form in EC and has been referred to as the extrahepatic isoform. It provides ornithine for polyamine synthesis, thereby controlling cell proliferation and differentiation. 12, 13 Arg2 also exhibits broad tissue distribution and is inducible by a variety of factors, including lipopolysaccharide (LPS), tumor necrosis factor (TNFα), and hypoxia. [14] [15] [16] [17] The role of Arg2 in endothelial dysfunction has recently been extended to other disorders in animal models, including aging, 7 ischemia reperfusion, 18, 19 hypertension, 20, 21 balloon vascular injury, 22 ischemia reperfusion injury, and atherosclerosis. 23 Our laboratories have demonstrated that OxLDL increases Arg2 activity in human aortic endothelial cells (HAEC) in a rapid, dose-dependent manner that leads to impaired endothelial NO synthesis. 24 However, the signaling pathways that connect OxLDL exposure to Arg2 in EC remain incompletely defined. Thrombin increases Arg2 activity in EC via the Rho/rho kinase (ROCK) signaling pathway, 25 and RhoA may also be important in OxLDL-mediated Arg2 activation in EC. 26 Another clue about its regulation is that Arg2 contains a putative mitochondrial targeting sequence in its amino terminus. Arg2 is thought to be largely, but not exclusively, confined to mitochondria in quiescent vascular EC, and we have shown that it constrains endothelial NOS activity. 27, 28 However, the mechanism by which mitochondrial Arg2 constrains the activity of (predominantly) cytosolic endothelial nitric oxide synthase (eNOS) is unclear. In the current study, we demonstrate that Arg2 release from mitochondria to cytoplasm triggers NO-dysregulated vascular dysfunction in rapid response to OxLDL exposure.
Methods
Detailed Methods are found in the Online Data Supplement, which includes the following:
Arginase activity assay was determined in lysates of HAEC and murine aortic tissue by measuring urea production.
For plaque quantification, vessels were stained with Sudan IV. Aortic roots were then paraffin-embedded, and cross sections were stained with hematoxylin-eosin to evaluate the atherosclerotic lesion area. Image analysis was done with Image J, version 1.42n. Some aortic segments were permeabilized with 0.5% Triton X-100 in 3% paraformaldehyde and then cut open to expose the intima, and Arg2 was imaged using a Zeiss 710-NLO confocal unit and Zeiss Zen software.
Ad-shNontargeted, Ad-mitochondrial processing peptidase (MPP) α, Ad-MPPβ, Ad-shArg1, and Ad-shArg2-encoded viruses were generated using a pAdBLOCK-iT kit (Life Sciences). An adenoviral construct containing green fluorescent protein (GFP) Arg2 was constructed by subsequent subcloning of C-terminal GFP epitope-tagged Arg2 into the PENTR1a entry and then into the PDEST destination vector.
For proteomics studies, cytosol and mitochondria were fractionated and immunoprecipitated from EC using Arg2 polyclonal antibody. Gel bands corresponding to both control and OxLDL-treated samples were excised, digested with LysC, and subjected to mass spectrometry (MS) analysis. Protein identification by liquid chromatography tandem MS analysis of peptides was performed using an LTQ ion trap MS (Thermo Fisher Scientific) interfaced with a 2-dimensional nanoLC system (Eksigent, Dublin, CA).
Superoxide and NO measurements were determined using the Luminol analog L-012, and a Siever NO analyzer, respectively. MPP activity was determined by measuring PINK1 cleavage.
Results

OxLDL Activates Endothelial Arg2 by Triggering Its Translocation From the Mitochondria to the Cytosol
Previously, we have shown that exposure of HAEC to OxLDL rapidly increases Arg2 activity. 24, 26 This time course is consistent with translocation between subcellular compartments and post-translational modification(s). Serum-starved HAEC were incubated with 50 μg/mL OxLDL for 2 hours. OxLDL exposure promoted robust translocation of Arg2 from mitochondria to the cytosol ( Figure 1A ). To confirm that Arg2 is predominantly targeted to mitochondria, FLAG epitopetagged Arg2 was expressed in HAEC cells ( Figure 1C and 1D). Immunofluorescence studies in unstimulated HAEC cells transfected with FLAG-tagged Arg2 also demonstrated that the majority of Arg2 is located in mitochondria ( Figure 1E ). Arginase activity was also measured in both mitochondrial and cytoplasmic fractions ( Figure 1B ). Interestingly, arginase activity was substantially increased in the cytosolic fraction of OxLDL-treated HAEC when compared with the activity of mitochondrial Arg2 in untreated cells. Although we and others have identified Arg2 as the predominant arginase isoform in HAEC, some reports indicate that Arg1 is expressed in ECs. 29 To determine the contribution of individual Arg isoforms to total arginase activity in HAEC, we individually silenced Arg1 and Arg2 using adenovirally mediated shRNA transduction. Arg2 silencing inhibited total arginase activity to <25% of control levels, whereas Arg1 knockdown had little effect on total HAEC arginase activity (Online Figure IA) . Furthermore, we did not detect any Arg1 expression in quiescent HAEC. These findings suggest that the OxLDL-induced increase in total arginase activity in HAEC is almost entirely mediated by Arg2.
To examine OxLDL-triggered translocation of Arg2 from mitochondria to cytosol in real time, we constructed an Arg2
Nonstandard Abbreviations and Acronyms: Changes in mitochondrial membrane potential have been shown to be linked to the decompartmentalization of mitochondrial proteins strongly 30 ; however, no change in mitochondrial membrane potential was observed in intact HAEC in response to OxLDL using the fluorescent probe tetramethylrhodamine methyl ester (TMRM) (Online Figure III ).
OxLDL-Mediated Cytosolic Release and Activation of Endothelial Arg2 Are Dependent on the LOX-1 Receptor and ROCK Activity
We have previously demonstrated that OxLDL-mediated increases in EC Arg activity are dependent on the LOX-1 receptor. 26 Here, we measured Arg2 quantity and activity in cytosolic and mitochondrial fractions of primary cultures of aortic ECs isolated from wild-type (WT) and LOX-1 receptor knockout mice (LOX-1 −/− ) in response to OxLDL. OxLDL failed to induce cytosolic release and activation of Arg2 in aortic EC from LOX-1 −/− mice (Figure 2A and 2B). This supports our previous finding that LOX-1 mediates acute OxLDL-induced increases in the activity of Arg2. 26 Our previous data 26 have demonstrated that RhoA and ROCK activation are downstream events in OxLDL-dependent augmentation of Arg2 activity in EC. To define the role of Rho signaling in OxLDL-dependent decompartmentalization and activation of Arg2, we preincubated HAEC with the specific ROCK inhibitor Y-27632 (10 μmol/L Y-27632; 2 hours), which obviated both OxLDL-induced cytosolic translocation of Arg2 and the associated increase in arginase activity ( Figure 2C and 2D).
Truncated Arg2 (Without the Mitochondrial Targeting Sequences) Localizes to the Cytoplasm of HAEC
Most nuclear-encoded proteins that are destined to be incorporated into mitochondria possess mitochondrial targeting sequences (MTS). Although it has been shown that Arg2 resides predominantly in mitochondria, 27 the MTS for Arg2 is still undefined and bioinformatics-based predictions of MTS of dualtargeted genes have shown to be inaccurate. 31 Identification and characterization of the Arg2 MTS were undertaken to understand the dual targeting of this protein and its regulation by the OxLDL stimulus. We used MS and N-terminal sequencing using Edman degradation analysis. MS analysis indicated that an immunoprecipitated (IP) cytosolic Arg2 from OxLDLtreated HAEC is cleaved at the His amino acid residue at position 24 ( Figure 3A ). MS analysis of an immunoprecipitation of Arg2 from the cytosolic fraction of HAEC that were treated with OxLDL provided 30% amino acid sequence coverage at 95% confidence and yielded the fragmentation spectrum shown in Figure 3A . Because the N terminus of this Arg2 peptide is not a LysC cleavage site, the N-terminal position of this Figure 1 . Oxidized low-density lipoprotein (OxLDL) triggers cytosolic release of activated arginase 2 (Arg2). Human aortic endothelial cells (HAECs) were incubated with 50 μg/mL OxLDL for 2 hours. Cell lysates were fractionated by differential centrifugation. A, The quantity of Arg2 was measured in cytosolic (C) and mitochondrial (M) fractions by Western blotting. Cell lysates were also immunoblotted for lactate dehydrogenase (LDH) and manganese superoxide dismutase to verify fractionation. B, Arginase activity was measured in the separated C and M fractions. C and D, HEK-293 cells were transfected with C-terminal FLAG epitope-tagged Arg2 and subjected to cytosolic and mitochondrial fractionation. Fractionated lysates were probed with FLAG antibody (C) and with cytochrome C antibody (D). E, FLAG-Arg2-transfected unstimulated HAECs were stained with mitotracker red CMXRos (red), anti-Flag primary antibody, AlexaFlour 488 mouse (green) secondary, and 4',6-diamidino-2phenylindole (DAPI) (blue) and analyzed by immunoflorescence. *P<0.05 vs control (CON) group; $P<0.05 Con (cytoplasm) vs Oxldl (cytoplasm) (B). sequence indicates that the Arg2 parent protein was cleaved (by an endogenous peptidase), leaving HSVAVIGAPFSQGQK as the N-terminal peptide, rather than the traditional LysC site (SVHSVAVIGAPGSQGQK). To investigate the amino acid(s) that form the N terminus of full-length Arg2 further, Edman degradation analysis was performed on immunoenriched C-terminal Flag-Arg2 isolated from HEK-293 cells. The N-terminal amino acid sequences obtained were from 2 peptides: VHSVAVIG and GQKRKGVEH. These data indicate potential cleavage sites between amino acids 22 and 23 and 35 and 36, respectively ( Figure 3B ). The second of these potential cleavage sites detected with Edman degradation was consistent with canonical sequences associated with cleavage by the MPP because it included arginine residues at positions −2 and −3 relative to the candidate site of cleavage. 32 To evaluate whether deletion of these putative MTS had functional consequences for Arg2 localization, we generated 2 N-terminal truncation mutants of Arg2 (deletion of resides, 1-22 or 1-40) as shown in Figure 4A . Deletion of either Arg2 amino acids 1 to 22 or 1 to 40 resulted in almost exclusive cytoplasmic distribution of Arg2 ( Figure 4B and 4C) . A point mutation of the MPP cleavage site at position 36 in Arg2 that was predicted by N-terminal sequencing significantly inhibited the translocation of Arg2 to mitochondria and attenuated Arg activity.
OxLDL-Induced Translocation and Activation of Arg2 in HAEC Involves the MPP
The MTS and putative MPP cleavage site in the N terminus of human Arg2 that we identified by MS and Edman degradation analysis are regions of Arg2 that are highly conserved among species ( Figure 5A ). Given the redistribution of mitochondrial Arg2 after OxLDL stimulation, we examined whether MPP, and therefore MTS cleavage, contributes to OxLDL-evoked reverse translocation of Arg2 from mitochondria to the cytosol. O-phenanthroline, a biochemical inhibitor of MPP, prevented the induction of Arg activity ( Figure 5B ) and completely blocked OxLDL-induced cytosolic release of Arg2 ( Figure 5C ). Interestingly, the competitive Arg inhibitor 2(S)-amino-6-boronhexanoic acid, while inhibiting Arg activity, did not prevent OxLDL-induced Arg2 translocation to the cytosol ( Figure 5B and 5C ). In addition, MPPα knockdown blocked cytosolic redistribution of Arg2 with OxLDL exposure and prevented Arg2 activation in response to OxLDL ( Figure 5D and 5E). However, control siRNA had no effect on MPP expression or on the distribution or activity of Arg2. The siRNA for MPP knocked down MPPα subunit protein abundance by ≥50% in HAEC ( Figure 5F ).
Immunofluorescence localization experiments were then conducted in native vascular ECs in aortic strips from transgenic mice with Tie2 promoter-driven endothelial-specific Arg2 overexpression 33 (Figure 6A ). Arg2 was confined to distinct perinuclear granular structures consistent with mitochondria in control samples. Stimulation of the aortic intima with OxLDL resulted in Arg2 redistribution to a diffuse blush consistent with cytoplasmic redistribution, and this was prevented in samples in which MPP was inhibited by O-phenanthroline (OPH). The same redistribution pattern was observed in Arg2-GFP-transduced HAEC ( Figure 6B ; Online Figure VIII ). In addition, although Arg2 was confined to the mitochondria in quiescent HAEC, OxLDL stimulation led to cytoplasmic translocation, a process that was inhibited by shRNA knockdown of either MPPα or MPPβ in HAEC ( Figure 6B ).
Inhibition or Knockdown of MPP Prevents OxLDL-Mediated Vascular Dysfunction and eNOS Uncoupling
OxLDL-incubated aortic rings transduced with 100 multiplicity of infection (MOI) of control shRNA (nontargeted) exhibited attenuated relaxation responses to acetylcholine (endothelial dysfunction). This was substantially improved in aortic rings that were transduced with 100 MOI of adenoviruses with shR-NA for either MPPα or MPPβ when added 24 hours before OxLDL stimulation ( Figure 6C and 6D ). MPPα and MPPβ knockdown in these vessels were verified by immunoblotting with MPPα-and MPPβ-specific antibodies (Online Figure V) .
The process termed eNOS uncoupling occurs under several pathological conditions in which the enzymatic reduction of molecular oxygen by eNOS is no longer coupled to l-arginine oxidation but leads to an increase in superoxide rather than NO production. OxLDL has been shown to decrease the bioavailability of NO by eNOS uncoupling. 34 This may occur in ECs because of depletion of l-arginine substrate available for eNOS in the presence of activated Arg2. 35, 36 We tested the effects of inhibiting MPP, and its role in the downstream cytosolic translocation and activation of Arg2, on eNOS uncoupling by OxLDL exposure. MPP inhibition blocked the increased reactive oxygen species (ROS) generation and the decreased NO production seen in aortas from WT (LOX-1 +/+ ) mice after OxLDL exposure ( Figure 7A and 7B). OxLDL induction of ROS production in aortas that were not treated with MPP inhibitors was inhibited by L-N Gnitroarginine methyl ester (L-NAME; 100 μmol/L), suggesting that eNOS was the source of ROS (via eNOS uncoupling) in these vessels. OxLDL had no effect on NO production and ROS generation in aortas from LOX-1 −/− mice. In addition, endothelium-denuded (E-) strips demonstrated little ROS production, suggesting that the endothelium is the primary source of the OxLDL-dependent ROS ( Figure 7C ). ROS was measured using the luminol analog L-012, and nitrite accumulation was measured using a Siever NO analyzer to determine NO production. The specificity of L-012 for superoxide was examined by treating cells with the superoxide scavenger (superoxide dismutase; 20U/mL). Superoxide dismutase nearly abolished signals from HAEC loaded with L-O12, indicating that chemiluminescence was specific to superoxide ( Figure 7D) . OxLDL significantly increased superoxide production in HAEC, which was further shown to be sensitive to superoxide dismutase. Adenoviral knockdown of either Arg2 or MPPα with human-specific shRNA significantly reduced OxLDL-dependent increases in ROS ( Figure 7E) , and MPPα knockdown obviated the drop in NO that was caused by OxLDL ( Figure 7F ).
To determine whether reduced levels of l-arginine contribute to OxLDL-mediated eNOS uncoupling, we measured the concentration of l-arginine in both the cytosolic and the mitochondrial compartments of HAEC in the presence and absence of OxLDL using a Biochrom-20 amino acid analyzer. OxLDL significantly diminished cytosolic l-arginine concentrations (Online Figure IV) . Inhibition of MPP with O-phenanthroline before OxLDL exposure prevented this OxLDL-dependent decrease in cytosolic l-arginine.
OxLDL Increases MPP Activity and Is Dependent on ROCK
We next used recent data identifying PINK1 cleavage as a metric for MPP activity 37 to interrogate the effects of ROCK and of OxLDL on MPP activity. FLAG-PINK1 cDNA alone or FLAG-PINK1 together with constitutively active or dominant negative mutants of ROCK were expressed in HAEC (Online Figure VI) . Cleaved PINK1 increased in the presence of constitutively active-ROCK, whereas PINK cleavage did not change when control GFP cDNA or dominant negative-ROCK were coexpressed. The negligible effect observed with dominant negative-ROCK may be attributed to its lower expression level when compared with active mutant (third segment of Online Figure VIA) . HAEC-expressing FLAG-PINK1 were also treated with OxLDL alone or in combination with the ROCK inhibitor Y-27632 (Online Figure VIB) . OxLDL upregulated PINK1 cleavage (and thus MPP activation), and this was inhibited by Y-27632. Taken together, these findings suggest a signaling cascade that is initiated by OxLDL and extends through RhoA and ROCK to MPP.
Arg2 Knockout Reduces Atheromatous Plaque Burden, Improves Endothelial Function, Enhances NO, and Reduces ROS in ApoE −/− Mice
Endothelial dysfunction and inflammation are 2 critical events that drive atherosclerosis. To investigate the role of Arg2 in endothelial inflammation, we examined OxLDL-dependent nuclear factor kappa light chain enhancer of activated B cells (NFκB) activity in the presence or absence of amino-2-borono-6-hexanoic acid. NFκB activity was determined by measuring luciferase activity that was driven by an NFκB response element. OxLDL increased NFκB activity, and this was significantly attenuated by amino-2-borono-6-hexanoic acid ( Figure 8A) .
Aortic atheromatous plaque burden was then determined in ApoE −/− and Arg2 −/− /ApoE −/− double knockout (DKO) mice (created by backcrossing the Arg2 −/− on an ApoE −/− background) that were fed an atherogenic diet for 12 weeks. Plaque thickness was significantly reduced in DKO mice when compared with ApoE −/− mice (178.6±25.6 versus 416.7±52.5 μm; P<0.01; Figure 8B , top and bottom panels) as was the percentage of total aortic surface area that was covered by plaque (38.4±3.8% versus 52.0±2.8%; n=6; P<0.01; Figure 8C , top and bottom panels). No plaque was detected in WT or Arg2 −/− mice.
We next determined vascular reactivity in response to acetylcholine (endothelial dependent) or sodium nitroprusside (endothelial independent) in isolated aortas from ApoE −/− and DKO mice that were fed a high cholesterol/high-fat diet. Endothelial-dependent vascular relaxation in response to acetylcholine was significantly improved in aortas from DKO mice when compared with aortas from ApoE −/− mice (log EC50=−5.68±0.31 versus −5.13±0.53 mol/L; P<0.05; n=6). Acetylcholine-mediated relaxation responses in vessels from WT and Arg2 −/− mice were significantly greater than in either the ApoE −/− or the DKO samples (log EC50=−5.79±0.23 and −6.05±0.29 mol/L, respectively; P<0.05; n=6; Figure 8D ). eNOS inhibition with L-NAME (100 μmol/L) abolished the relaxation in response to acetylcholine in all groups, suggesting that the differences seen between groups were because of eNOS activity (Online Figure VII) . Sodium nitroprussidemediated relaxation (endothelium-independent responses) in samples from WT and Arg2 −/− mice was not significantly different than those seen in ApoE −/− or DKO mice ( Figure 8E ). We next tested whether genetic deletion of Arg2 ameliorated changes in NO and ROS production that were seen in atheroprone ApoE −/− mice that were fed a high cholesterol diet. Aortic intima from DKO animals exhibited improved NO production and lower ROS levels when compared with those measured in samples from ApoE −/− mice (Online Figure IX) . The atherogenic diet did not change NO production in Arg2 −/− mice (P=0.36).
Discussion
In the current study, we show that OxLDL triggers rapid reverse translocation of Arg2 from mitochondria to cytoplasm in EC. This retrograde translocation of Arg2 to cytosol significantly augments its activity and is dependent on processing by MPP. Furthermore, using LOX-1 −/− KO mice and ROCK inhibitors, we demonstrate that OxLDL-mediated activation and movement of Arg2 to the cytoplasm is mediated through the LOX-1 receptors on HAEC and requires ROCK-mediated signaling. Finally, we show that eNOS uncoupling is a biologically critical consequence of these changes in Arg2 localization and activity, with subsequently reduced NO production and increased generation of ROS.
Many mitochondrial proteins are encoded by nuclear genes, synthesized in the cytosol as large precursor proteins with N-terminal MTSs, and imported into mitochondria. 38 During or after import, precursor proteins may be cleaved by MPP Figure 7 . Oxidized low-density lipoprotein (OxLDL)-mediated endothelial nitric oxide (NO) synthase uncoupling is dependent on mitochondrial processing peptidase (MPP) and intact endothelium. Aortic strips from wild-type or LOX-1 −/− mice were exposed to OxLDL alone, OxLDL with 5 mmol/L O-phenanthroline (Oph), or OxLDL plus L-N G -nitroarginine methyl ester (L-NAME; 100 μmol/L). A, Reactive oxygen species (ROS) production was measured as the slope of dihydroethidium (DHE) fluorescence. B, NO production was measured as a slope of DAF fluorescence. C, ROS production was also studied in parallel in murine aortic specimens with intact (E+) or mechanically denuded (E−) intimal endothelium. D, Human aortic endothelial cells (HAECs) production of ROS was determined by L-012 chemiluminescence after incubation with or without superoxide dismutase (SOD; 20 U/mL) and expressed as relative light units (RLU). E, HAECs were incubated with 100 multiplicity of infection (MOI) of nontargeted (NT), MPPα, or MPPβ shRNA adenoviruses. Twenty-four-hours after transduction, media were replaced with fresh media with or without OxLDL (50 μg/mL). After 48 hours, the production of ROS was determined in the presence or absence of SOD (20 U/mL) via L-012 chemiluminescence. F, HAECs were incubated with 100 MOI of NT shRNA or MPPα shRNA adenoviruses. Cells were treated the next day with control medium or OxLDL (50 μg/mL). After 48 hours, the production of NO was determined by measuring nitrite levels with Siever NO analyzer, mean±SE are shown, n=6. *P<0.05 vs control (Con), #P<0.05 vs OxLDL. leaving a functional protein. 39 The positively charged MTS are recognized directly by mitochondrial surface receptors and also facilitate translocation into mitochondria by interacting with the membrane electric potential that exists across the mitochondrial inner membrane. Some proteins, such as fumarase, may undergo bidirectional trafficking between cytosol and mitochondria based on processing by MPP. 40 Our data indicate that Arg2 is dual-targeted to mitochondria and the cytosol, thereby adding Arg2 to several other proteins that share this distinction-up to one quarter of the mitochondrial proteome in some species. 41 There are ≥4 potential mechanisms by which a single translation product may be present in dual compartments. These include an ambiguous targeting sequence recognized by ≥1 organelle, multiple targeting sequences; differential targeting accessibility; and reverse translocation-a mechanism that may be dependent on processing of a MTS in the mitochondria. 42 Our data implicate the latter mechanism in the subcellular trafficking of Arg2. Reverse translocation-based dual targeting of proteins to mitochondria and cytosol in response to altered cellular environment or stress (such as OxLDL exposure) has not been previously described in mammalian cells and represents a novel mechanism of cellular regulation in health and disease. Data supporting this mechanism in the current study include the demonstrated dependence of localization on both an intact MTS and on the activity of MPP because the inhibition of MPP in HAEC by either pharmacological or siRNA approaches abolished the cytosolic release and activation of Arg2 in response to OxLDL.
We used experimental data from MS and N-terminal sequencing using Edman degradation analysis followed by genetic mutations to identify and characterize candidates for the MTS and the MPP cleavage site. Differences in the N-terminal residues of cleaved Arg2 that were found by MS and Edman degradation (HSVAV versus VHSVAV, respectively) may be explained by post-MPP cleavage trimming by other mitochondrial peptidases. 43 Our findings that mutations of the predicted MPP cleavage site inhibited mitochondrial localization of Arg2 and attenuated its activity suggest that processing of Arg2 in mitochondria is a requirement for its activation. This proposed mechanism of dual localization has been characterized in yeast, where the Krebs cycle enzyme fumarase is distributed between the mitochondria and the cytoplasm based on metabolic cues from the glycoxylate shunt. The enzyme is first targeted to the mitochondria by an MTS (24 amino acids at the N-terminal sequence) that is processed by MPP. A population of the enzyme then moves back onto the cytoplasm in a process that is regulated by protein folding. One possible mechanism for reverse translocation of Arg2 in the current study is regulation of Arg2 folding by a chaperone protein, such as HSP60, a mitochondrial protein that is released into the cytoplasm in response to endothelial activation with exposure to OxLDL 44 and which we have shown to be a binding partner for Arg2 (unpublished observation).
Despite our finding that the majority of Arg2 is confined to the mitochondria, arginase activity in the cytosol and mitochondrial fractions was comparable. This finding suggests that cytosolic Arg2 is more active than mitochondrial Arg2. This could clarify some controversies on the arginine paradox-the increased production of NO with addition of extracellular arginine, despite saturated levels of intracellular l-arginine. 45 Our findings that the single translation product of Arg2 could be localized in 2 separate compartments on cellular stress, and that Arg2 can constrain eNOS activity supports the concept that specific subcellular pools of l-arginine do exist. We speculate that Arg2 is in closer proximity to binding and regulatory proteins that enhance its function after its translocation to cytosol. Recent studies demonstrate that arginine succinate lyase enhanced NO production by NOS through recycling citrulline to l-arginine and maintaining the integrity of the NOS complex. Similarly, cytosolic arginine succinate lyase could recycle l-citrulline to l-arginine and provide substrate for Arg2 and maintain its structural complex in an active conformation. 46 Activation of ROCK has been linked to the acceleration of atherosclerosis in a mouse model. 47 Furthermore, we have demonstrated that RhoA and ROCK are critical to OxLDL-dependent increases in EC Arg activity. 26 In the current study, we present data demonstrating that inhibition of ROCK with Y-27632 prevented rises in both cytosolic Arg2 content and activity after OxLDL stimulation. These new data suggest that ROCK facilitates OxLDL-evoked activation and redistribution of Arg2.
Although it is assumed that the mechanism of eNOS uncoupling by arginase upregulation is, in part, related to arginasedependent decrements in l-arginine availability, changes in l-arginine concentrations in response to OxLDL have not been measured in individual cellular compartments. Our data demonstrate that OxLDL significantly diminished cytosolic l-arginine concentrations (Online Figure IV) . These findings are consistent with our hypothesis that Arg2, which is normally confined to the mitochondria, changes to a cytosolic distribution with OxLDL stimulation and uncouples eNOS in the cytosol. Furthermore, inhibition of MPP both attenuated the increase in cytoplasmic arginase activity and prevented an OxLDL-dependent decrease in cytosolic l-arginine ( Figure 5 ; Online Figure IV) .
In conclusion, the reverse translocation of Arg2 from its MTS-directed sequestration in mitochondria to the cytosol in response to OxLDL apparently underlies a novel mechanism for OxLDL-mediated increases in Arg activity in HAEC. This study identifies MPP as a new subject for targeted therapeutics for atherosclerosis and other vascular disorders in which Arg2 interrupts NO production and promotes the generation of injurious ROS by uncoupling eNOS.
